Grantham, Mayo, Van Otterloo & Co (GMO)’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
6,792
+940
| +16% | +$174K | ﹤0.01% | 420 |
|
|
2025
Q1 | $1.23M | Sell |
5,852
-1,381
| -19% | -$289K | ﹤0.01% | 419 |
|
|
2024
Q4 | $1.29M | Buy |
7,233
+1,054
| +17% | +$187K | ﹤0.01% | 409 |
|
|
2024
Q3 | $1.22M | Buy |
+6,179
| New | +$1.22M | ﹤0.01% | 413 |
|
|
2021
Q1 | – | Sell |
-31,210
| Closed | -$3.34M | – | 832 |
|
|
2020
Q4 | $3.34M | Buy |
31,210
+6,000
| +24% | +$643K | 0.02% | 354 |
|
|
2020
Q3 | $2.21M | Buy |
+25,210
| New | +$2.21M | 0.02% | 388 |
|
|
2019
Q3 | – | Sell |
-18,253
| Closed | -$1.33M | – | 719 |
|
|
2019
Q2 | $1.33M | Buy |
+18,253
| New | +$1.33M | 0.01% | 496 |
|
|
2018
Q4 | – | Sell |
-19,253
| Closed | -$1.82M | – | 519 |
|
|
2018
Q3 | $1.82M | Sell |
19,253
-263,200
| -93% | -$24.9M | 0.01% | 313 |
|
|
2018
Q2 | $26.2M | Buy |
282,453
+162,253
| +135% | +$15M | 0.19% | 82 |
|
|
2018
Q1 | $11.4M | Buy |
120,200
+105,300
| +707% | +$9.97M | 0.07% | 137 |
|
|
2017
Q4 | $1.44M | Hold |
14,900
| – | – | 0.01% | 331 |
|
|
2017
Q3 | $1.32M | Buy |
14,900
+400
| +3% | +$35.5K | 0.01% | 338 |
|
|
2017
Q2 | $1.05M | Buy |
14,500
+9,000
| +164% | +$652K | 0.01% | 344 |
|
|
2017
Q1 | $358K | Buy |
+5,500
| New | +$358K | ﹤0.01% | 396 |
|
|
2014
Q2 | – | Sell |
-66,200
| Closed | -$3.4M | – | 489 |
|
|
2014
Q1 | $3.4M | Sell |
66,200
-217,891
| -77% | -$11.2M | 0.01% | 348 |
|
|
2013
Q4 | $15M | Sell |
284,091
-235,099
| -45% | -$12.4M | 0.04% | 169 |
|
|
2013
Q3 | $23.2M | Buy |
519,190
+497,890
| +2,338% | +$22.3M | 0.06% | 130 |
|
|
2013
Q2 | $881K | Buy |
+21,300
| New | +$881K | ﹤0.01% | 476 |
|